Singapore markets closed
  • Straits Times Index

    3,270.98
    -11.90 (-0.36%)
     
  • S&P 500

    4,145.19
    -6.75 (-0.16%)
     
  • Dow

    32,803.47
    +76.67 (+0.23%)
     
  • Nasdaq

    12,657.55
    -63.04 (-0.50%)
     
  • BTC-USD

    24,110.73
    +979.35 (+4.23%)
     
  • CMC Crypto 200

    564.39
    +29.17 (+5.45%)
     
  • FTSE 100

    7,491.04
    +51.30 (+0.69%)
     
  • Gold

    1,798.90
    +7.70 (+0.43%)
     
  • Crude Oil

    87.85
    -1.16 (-1.30%)
     
  • 10-Yr Bond

    2.8030
    -0.0370 (-1.30%)
     
  • Nikkei

    28,249.24
    +73.37 (+0.26%)
     
  • Hang Seng

    20,045.77
    -156.17 (-0.77%)
     
  • FTSE Bursa Malaysia

    1,496.03
    -5.52 (-0.37%)
     
  • Jakarta Composite Index

    7,086.85
    +2.19 (+0.03%)
     
  • PSE Index

    6,434.24
    +28.74 (+0.45%)
     
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Wall Street pares gains on report of potential coronavirus drug failing trial

·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

(Reuters) - Wall Street's main indexes pared gains sharply on Thursday, after a report that Gilead Sciences experimental coronavirus drug flopped in its first randomized clinical trial.

The Chinese trial showed that Gilead's antiviral, remdesivir, did not improve patients' condition or reduce the pathogen's presence in the bloodstream, the Financial Times reported, citing draft documents published accidentally by the World Health Organization.

At 12:51 a.m. ET the Dow Jones Industrial Average was up 68.61 points, or 0.29%, at 23,544.43, the S&P 500 was up 7.46 points, or 0.27%, at 2,806.77 and the Nasdaq Composite was up 33.58 points, or 0.40%, at 8,528.96.

(Reporting by Shreyashi Sanyal in Bengaluru; Editing by Anil D'Silva)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting